AIM AIM ImmunoTech

$AIM If you had a 400k promissory note would you accept shares in exchange? Think it settles the so called imminent reverse split possibility a more unlikely outcome! Not saying never but this confidence is at least more optimistic for the immediate future.

$AIM Equels acquired 22,000 shares at $0.221 for a total of $4,862. He probably pays more than that per week to feed and care for his horses. Buying such a piddling amount is akin to damning with faint praise.

$AIM with the ebola outbreak seems to be 0 shares availability for shorting ~ 🍋💦 squeeze time ⏲️

$AIM When was the last time that a press release from this company prestented some actual news rather than just repeating stale pumps?

$AIM the criminal shorts are still connected in the hart of the company every time news is on the way they short harder. Trading on such info is illegal. It’s called insider trading.

$AIM AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib

$AIM Some perspective on recent CEO purchases. CEO salary was published in the 10K released in March 2026 - CEO Salary in 2025 $575K (total comp ~$820K) - CEO Salary in 2024 $783K (total comp ~$1M) Form-4 as of 9/17/26 lists the CEO share count at 102,822 which at the current price is less than $25K in company stock. CEO Equels has experienced the same loss of value as other shareholders, but his share ownership does not align with his compensation. Any insider buying is better than no buying, but the level of insider ownership at AIM is abysmal. It is a challenge to convince investor to use capital when insider don't have any material capital on the line.

$AIM How can a stock have such high volume as AIM has had for the past few weeks and trade in such a narrow range? Pre market trading and after hours trading volume is high. And the stock price doesn't move more than a cent. Is it shorts covering their naked positions? Is our market maker involved? Somebody please explain.

$AIM Just food for thought. About a month ago I Grok'd what was a microcap company that might 10x. Besides a bunch of warning caveats it gave one example stock. This one.

$AIM this company spends more time figuring out new ways to scam new investors then it does getting their drug over the finish line with a deal with big Pharma. Pathetic leadership

$AIM bastards, spent another 5 grand .25 now at .18, averaging down for sure. 60g tied up in this now...

$AIM I'm not sure what impact having the company's lawyer/CEO read a press release to a webcam in his den/office will have. But, I suppose that it is kind of entertaining in its own sort of way. It kind of reminded me of what it was like watching Biden trying to read a speech off of a teleprompter near the end of his term.

$AIM AIM leadership has led AIM shareholders to an all-time new low today, 9/25/2026. - Down 99.9% in past 5 years - Down 92.7% in past 1 year The leadership team that has overseen this destruction of value still get compensated and have remained in their roles despite their monumental failures. On 9/22/26, AIM issued a bizarre press release about Revolution Medicine's daraxonrasib, an FDA approved drug. It appears that AIM leadership thinks a comparison between ampligen and daraxonrasib is a wise decision, but daraxonrasib is FDA approved and a Phase 3 with 500 enrollments. (NCT06625320). Completely bizarre.

$AIM Intellectual Property & Patent Expansions Long COVID Protection: AIM significantly expanded its global patent portfolio, securing patent protection in Europe and the United Kingdom covering Ampligen for Long COVID, extending exclusivity through June 2041. Oncology Combinations: The U.S. Patent and Trademark Office (USPTO) granted a broad patent covering the use of Ampligen in combination with pembrolizumab (Keytruda) for cancer treatment, protecting the IP landscape through 2039.

$AIM Has to be one of the most mysterious shares ever. $2.5 million changed hands today for a share no one is interested in?….there has to be something to it’s never say die existence….

$AIM I like this stock. Slow climb then explosive 🧨? Maybe today, maybe next week, but I’m holding a big bag just over .20 right now. Let’s bring er back to life

$AIM at this price it’s ultra easy to buy up potential. Give it some volume, some buyers (which can buy copious amounts), and Boom Shaka Lakka

$AIM Some may believe we have witnessed years of fraud for the benefit of the shorts. Has there been perpetual hyoe but no delivery? Let others decide.

$AIM Tom is playing resident evil . The small buys make a difference distorting their manipulation

$AIM this junk robbed my 20k covid time. Still robbing money from investors. Must remove from stock market.